Trump Threatens 100% Tariff on Generic Drugs in US Push

President Donald Trump has threatened to impose 100% tariffs on generic drugs, a significant escalation of his strategy against the pharmaceutical industry since the start of his second term. The threat, reported by Bloomberg, is part of his "Made in USA" push.

Details of the Action

The threat of 100% tariffs on generic drugs is part of Trump's broader campaign to boost domestic manufacturing. The administration has not yet specified a timeline for implementation, but it represents a major escalation in pressure on drug companies.

Company Response

Pfizer (PFE) has not yet issued an official response. However, like other pharmaceutical companies, it relies on global supply chains and could be significantly affected if the tariffs are imposed.

Precedents and Context

This is not the first time Trump has used tariff threats against the pharmaceutical industry. Since his second term, he has imposed tariffs on some imported drugs, but this time specifically targets generic drugs, which make up a large portion of the drug market.

Potential Financial Impact

If implemented, 100% tariffs could significantly increase the cost of generic drugs, potentially affecting profits for companies like Pfizer. It may also push companies to restructure supply chains or move production to the US, which could take time and incur additional costs.